Healthcare Industry Type 1 Diabetes (T1D) Market Size | Page 4

Your Catalyst To a Lucrative Business
5.3. China
5.3.1. Market estimates and forecast, 2014 - 2024 (USD Million)
5.3.2. Market estimates and forecast, by insulin analog, 2014 - 2024 (USD Million)
5.4. India
5.4.1. Market estimates and forecast, 2014 - 2024 (USD Million)
5.4.2. Market estimates and forecast, by insulin analog, 2014 - 2024 (USD Million)
Chapter 6. Competitive Landscape
6.1. Competitive landscape analysis, 2016
6.2. Strategic framework
6.3. Potential customer base concentration
6.4. Company market positioning
6.5. Company profiles
6.5.1. ADOCIA
6.5.1.1. Company Overview
6.5.1.2. Product Benchmarking
6.5.1.3. Financial Performance
6.5.1.4. Recent Initiatives
6.5.2. Biocon
6.5.2.1. Company Overview
6.5.2.2. Product Benchmarking
6.5.2.3. Financial Performance
6.5.2.4. Recent Initiatives
6.5.3. Bioton
6.5.3.1. Company Overview
6.5.3.2. Product Benchmarking
6.5.3.3. Financial Performance
6.5.3.4. Recent Initiatives
6.5.4. Eli Lilly and Company
6.5.4.1. Company Overview
6.5.4.2. Product Benchmarking
6.5.4.3. Financial Performance
6.5.4.4. Recent Initiatives
6.5.5. Novo Nordisk
6.5.5.1. Company Overview
6.5.5.2. Product Benchmarking
6.5.5.3. Financial Performance
6.5.5.4. Recent Initiatives
6.5.6. Sanofi
6.5.6.1. Company Overview
6.5.6.2. Product Benchmarking
6.5.6.3. Financial Performance
6.5.6.4. Recent Initiatives
6.5.7. Wockhardt
6.5.7.1. Company Overview
6.5.7.2. Product Benchmarking
Follow Us: